Cargando…

PEGylation Extends Circulation Half-Life While Preserving In Vitro and In Vivo Activity of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1)

Excess proteolytic activity of matrix metalloproteinases (MMPs) contributes to the development of arthritis, cardiovascular diseases and cancer progression, implicating these enzymes as therapeutic targets. While many small molecule inhibitors of MMPs have been developed, clinical uses have been lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batra, Jyotica, Robinson, Jessica, Mehner, Christine, Hockla, Alexandra, Miller, Erin, Radisky, Derek C., Radisky, Evette S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502186/ https://www.ncbi.nlm.nih.gov/pubmed/23185522 http://dx.doi.org/10.1371/journal.pone.0050028

Ejemplares similares

Matrix Metalloproteinase-10/TIMP-2 Structure and Analyses Define Conserved Core Interactions and Diverse Exosite Interactions in MMP/TIMP Complexes
por: Batra, Jyotica, et al.
Publicado: (2013)

Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
por: Mehner, Christine, et al.
Publicado: (2014)

Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10
por: Raeeszadeh-Sarmazdeh, Maryam, et al.
Publicado: (2022)

Targeting an autocrine IL-6 – SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma
por: Mehner, Christine, et al.
Publicado: (2020)

PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma
por: Ma, Honghai, et al.
Publicado: (2019)

Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma
por: Mehner, Christine, et al.
Publicado: (2022)

Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2010)

Bad Tumors Made Worse: SPINK1
por: Mehner, Christine, et al.
Publicado: (2019)

Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2017)

Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma
por: Mehner, Christine, et al.
Publicado: (2015)

TIMP-1 attenuates blood–brain barrier permeability in mice with acute liver failure
por: Chen, Feng, et al.
Publicado: (2013)

Matrix Metalloproteinase-10 Is Required for Lung Cancer Stem Cell Maintenance, Tumor Initiation and Metastatic Potential
por: Justilien, Verline, et al.
Publicado: (2012)

Combinatorial engineering of N-TIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell
por: Arkadash, Valeria, et al.
Publicado: (2018)

Mapping protein selectivity landscapes using multi-target selective screening and next-generation sequencing of combinatorial libraries
por: Naftaly, Si, et al.
Publicado: (2018)

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers
por: Mehner, Christine, et al.
Publicado: (2015)

Mirolysin structures open a window on gum disease
por: Radisky, Evette S.
Publicado: (2020)

Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
por: Hayun, Hezi, et al.
Publicado: (2023)

Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
por: Hayun, Hezi, et al.
Publicado: (2023)

EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
por: Mehner, Christine, et al.
Publicado: (2017)

MYC Suppresses Cancer Metastasis by Direct Transcriptional Silencing of αv and β3 Integrin Subunits
por: Liu, Hong, et al.
Publicado: (2012)

miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype
por: Radisky, Derek C
Publicado: (2011)

Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion
por: Di Gregoli, Karina, et al.
Publicado: (2016)

Novel Pathogenic PRSS1 Variant p.Glu190Lys in a Case of Chronic Pancreatitis
por: Jancsó, Zsanett, et al.
Publicado: (2019)

An evaluation of matrix metalloproteinase-9 (Mmp-9) and tissue inhibitor metalloproteinase-1 (Timp-1) Serum levels and the Mmp-9/Timp-1 Ratio in Covid-19 patients
por: Demir, Nazlim Aktug, et al.
Publicado: (2023)

93rd Annual Meeting of the American Association for Cancer Research, San Francisco, CA, USA, 6-10 April 2002
por: Novaro, Virginia, et al.
Publicado: (2002)

Tyrosine Sulfation of Human Trypsin Steers S2’ Subsite Selectivity towards Basic Amino Acids
por: Szabó, András, et al.
Publicado: (2014)

Matrix metalloproteinase MMP-8, TIMP-1 and MMP-8/TIMP-1 ratio in plasma in methicillin-sensitive Staphylococcus aureus bacteremia
por: Forsblom, Erik, et al.
Publicado: (2021)

Avidity observed between a bivalent inhibitor and an enzyme monomer with a single active site
por: Lacham-Hartman, Shiran, et al.
Publicado: (2021)

PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
por: Schlapschy, Martin, et al.
Publicado: (2013)

A breast cancer progression model: the importance of three-dimensional tissue architecture and metalloproteinases
por: Bissell, MJ, et al.
Publicado: (2005)

Upregulation of matrix metalloproteinase 9 (MMP9)/tissue inhibitor of metalloproteinase 1 (TIMP1) and MMP2/TIMP2 ratios may be involved in lipopolysaccharide-induced acute lung injury
por: Chen, Guobing, et al.
Publicado: (2020)

Mammary Involution and Breast Cancer Risk: Transgenic Models and Clinical Studies
por: Radisky, Derek C., et al.
Publicado: (2009)

ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-κB-dependent activation of Snail
por: Cichon, Magdalena A., et al.
Publicado: (2014)

Cutting the brakes and flooring the gas: how TMEPAI turns TGF-β into a tumor promoter
por: Cichon, Magdalena A., et al.
Publicado: (2014)

Regulation of mechanical stress by mammary epithelial tissue structure controls breast cancer cell invasion
por: Radisky, Derek C., et al.
Publicado: (2013)

Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer
por: Cichon, Magdalena A, et al.
Publicado: (2014)

Inflammation, Infiltration, and Evasion—Tumor Promotion in the Aging Breast
por: Cruz-Reyes, Nicole, et al.
Publicado: (2023)

Climbing Up and Down Binding Landscapes through Deep Mutational Scanning of Three Homologous Protein–Protein Complexes
por: Heyne, Michael, et al.
Publicado: (2021)

Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma.
por: Joo, Y. E., et al.
Publicado: (1999)

Expression of Tissue Inhibitors of Metalloproteinases (TIMPs) in Hepatocellular Carcinoma
por: Joo, Young-Eun, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_vv5te9r8u4147nm4iuls5srqp5